Management of herpes zoster and postherpetic neuralgia

Journal of the American Academy of Dermatology

Volumn 57, Issue 6 SUPPL., 2007, Pages

  Tyring, Stephen K ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMITRIPTYLINE; ANTIVIRUS AGENT; BUPIVACAINE; CAPSAICIN; CORTICOSTEROID; DESIPRAMINE; FAMCICLOVIR; GABAPENTIN; LIDOCAINE; METHADONE; METHYLPREDNISOLONE ACEPONATE; MORPHINE; NARCOTIC ANALGESIC AGENT; NORTRIPTYLINE; OXYCODONE; PLACEBO; PREDNISOLONE; PREGABALIN; TRICYCLIC ANTIDEPRESSANT AGENT; VALACICLOVIR;

ANALGESIA; ANOREXIA; ARTICLE; ATAXIA; BACKACHE; BURNING SENSATION; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CORTICOSTEROID THERAPY; DIZZINESS; DROWSINESS; DRUG CHOICE; DRUG HALF LIFE; DRUG SAFETY; ERYTHEMA; FLUSHING; GASTROINTESTINAL SYMPTOM; HEADACHE; HEART ARRHYTHMIA; HERPES ZOSTER; HERPES ZOSTER OPHTHALMICUS; HUMAN; INFECTION; NAUSEA; ORTHOSTATIC HYPOTENSION; PALLIATIVE THERAPY; PATIENT COMPLIANCE; PERIPHERAL EDEMA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH; SEDATION; SIDE EFFECT; SOMNOLENCE; SWEATING; UNSPECIFIED SIDE EFFECT; URINE RETENTION; VISUAL DISORDER; VOMITING; XEROSTOMIA;

ADRENAL CORTEX HORMONES; AGED; ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIVIRAL AGENTS; CAPSAICIN; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HERPES ZOSTER; HUMANS; LIDOCAINE; MIDDLE AGED; NEURALGIA, POSTHERPETIC; PALLIATIVE CARE;

EID: 36048960424     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2007.09.016     Document Type: Article

References (36)

1. Katz J., Cooper E.M., Walther R.R., Sweeney E.W., and Dworkin R.H. Acute pain in herpes zoster and its impact on health-related quality of life. Clin Infect Dis 39 (2004) 342-348
2. Stankus S.J., Dlugopolski M., and Packer D. Management of herpes zoster (shingles) and postherpetic neuralgia. Am Fam Physician 61 (2000) 2437-2438
3. Choo P.W., Galil K., Donahue J.G., Walker A.M., Spiegelman D., and Platt R. Risk factors for postherpetic neuralgia. Arch Intern Med 157 (1997) 1217-1224
4. Gnann Jr. J.W., and Whitley R.J. Clinical practice: herpes zoster. N Engl J Med 347 (2002) 340-346
5. Alper B.S., and Lewis P.R. Does treatment of acute herpes zoster prevent or shorten postherpetic neuralgia?. J Fam Pract 49 (2000) 255-264
6. Decroix J., Partsch H., Gonzalez R., Mobacken H., Goh C.L., Walsh L., et al., Valacyclovir International Zoster Assessment Group (VIZA). Factors influencing pain outcome in herpes zoster: an observational study with valacyclovir. J Eur Acad Dermatol Venereol 14 (2000) 23-33
7. Tyring S.K., Beutner K.R., Tucker B.A., Anderson W.C., and Crooks R.J. Antiviral therapy for herpes zoster: randomized, controlled clinical trial of valacyclovir and famciclovir therapy in immunocompetent patients 50 years and older. Arch Fam Med 9 (2000) 863-869
8. Wood M.J., Kay R., Dworkin R.H., Soong S.J., and Whitley R.J. Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis 22 (1996) 341-347
9. Kost R.G., and Straus S.E. Postherpetic neuralgia-pathogenesis, treatment, and prevention. N Engl J Med 335 (1996) 32-42
10. Beutner K.R., Friedman D.J., Forszpaniak C., Andersen P.L., and Wood M.J. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 39 (1995) 1546-1553
11. Shen M.C., Lin H.H., Lee S.S., Chen Y.S., Chiang P.C., and Liu Y.C. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster. J Microbiol Immunol Infect 37 (2004) 75-81
12. Shafran S.D., Tyring S.K., Ashton R., Decroix J., Forszpaniak C., Wade A., et al. Once, twice, or three times daily famciclovir compared with acyclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial. J Clin Virol 29 (2004) 248-253
13. Tyring S., Barbarash R.A., Nahlik J.E., Cunningham A., Marley J., Heng M., et al., Collaborative Famciclovir Herpes Zoster Study Group. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia: a randomized, double-blind, placebo-controlled trial. Ann Intern Med 123 (1995) 89-96
14. Brentjens MH, Torres G, He J. Reduction of postherpetic neuralgia in herpes zoster: a study of the effects of gabapentin with valacyclovir during acute zoster outbreaks. Presented at: American Academy of Dermatology Annual Meeting; March 21-26, 2003; San Francisco, CA. Poster P38.
15. Cobo L.M., Foulks G.N., Liesegang T., Lass J., Sutphin J.E., Wilhelmus K., et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology 93 (1986) 763-770
16. Tyring S., Engst R., Corriveau C., Robillard N., Trottier S., Van Slycken S., et al. Famciclovir for ophthalmic zoster: a randomized acyclovir controlled study. Br J Ophthalmol 85 (2001) 576-581
17. Colin J., Prisant O., Cochener B., Lescale O., Rolland B., and Hoang-Xuan T. Comparison of the efficacy and safety of valacyclovir and acyclovir for the treatment of herpes zoster ophthalmicus. Ophthalmology 107 (2000) 1507-1511
18. Balfour Jr. H.H., Bean B., Laskin O.L., Ambinder R.F., Meyers J.D., Wade J.C., et al. Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med 308 (1983) 1448-1453
19. Tyring S., Belanger R., Bezwoda W., Ljungman P., Boon R., and Saltzman R.L. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients. Cancer Invest 19 (2001) 13-22
20. Brentjens MH, Torres G, He J. A double-blind randomized study of the use of 2 grams vs 1 gram of valacyclovir TID for 7 days in the treatment of acute herpes zoster in immunocompromised patients. Presented at: American Academy of Dermatology Annual Meeting; March 21-26, 2003; San Francisco, CA. Poster P455.
21. Wood M.J., Johnson R.W., McKendrick M.W., Taylor J., Mandal B.K., and Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med 330 (1994) 896-900
22. Whitley R.J., Weiss H., Gnann Jr. J.W., Tyring S., Mertz G.J., Pappas P.G., et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med 125 (1996) 376-383
23. Esmann V., Geil J.P., Kroon S., Fogh H., Peterslund N.A., Petersen C.S., et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet 2 (1987) 126-129
24. Dworkin R.H., and Schmader K.E. Treatment and prevention of postherpetic neuralgia. Clin Infect Dis 36 (2003) 877-882
25. Neurontin. [package insert] (2005), Parke-Davis, Division of Pfizer Inc, New York, NY
26. Lidoderm. [package insert] (2006), Endo Pharmaceuticals Inc, Chadds Falls, PA
27. Watson C.P. A new treatment for postherpetic neuralgia. N Engl J Med 343 (2000) 1563-1565
28. Dworkin R.H., Corbin A.E., Young Jr. J.P., Sharma U., LaMareaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
29. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. JAMA 280 (1998) 1837-1842
30. Rice A.S., and Maton S. Gabapentin in postherpetic neuralgia: a randomized, double blind, placebo controlled study. Pain 94 (2001) 215-224
31. Rowbotham M.C., Davies P.S., Verkempinck C., and Galer B.S. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65 (1996) 39-44
32. Watson C.P., Tyler K.L., Bickers D.R., Millikan L.E., Smith S., and Coleman E. A randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin Ther 15 (1993) 510-526
33. Watson C.P., and Babul N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 50 (1998) 1837-1841
34. Raja S.N., Haythornthwaite J.A., Pappagallo M., Clark M.R., Travison T.G., Sabeen S., et al. Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 59 (2002) 1015-1021
35. Dworkin R.H., Backonja M., Rowbotham M.C., Allen R.R., Argoff C.R., Bennett G.J., et al. Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. Arch Neurol 60 (2003) 1524-1534
36. Dworkin R.H., Johnson R.W., Breuer J., Gnann J.W., Levin M.J., Backonja M., et al. Recommendations for the management of herpes zoster. Clin Infect Dis 44 Suppl (2007) S1-S26